These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 741915)

  • 1. [Effect of lipid-lowering treatment with xanthinol-nicotinate on the carbohydrate metabolism in mature-onset diabetics and non-diabetic patients with hyperlipoproteinemias (HLP)].
    Haacke H; Parwaresch MR; Rube O; Mäder C
    Verh Dtsch Ges Inn Med; 1978; (84):1157-60. PubMed ID: 741915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
    Machalke K; Djaja S; Richter E
    Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV].
    Haacke H; Parwaresch MR; Mäder C
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():829-32. PubMed ID: 1029294
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of xanthinol nicotinate treatment on platelet aggregation.
    Seidel G; Endell W
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon].
    Willmen HR; Kogel H
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):133-8. PubMed ID: 1254378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological properties and clinical use of xanthinol nicotinate].
    Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV
    Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of beta1-24-corticotropic hormone, angiotensin II and xanthinol nicotinate on the kinetics of aldosterone.
    Pinsker P; Bultasová H; Bláha V; Vavrejn B
    Rev Czech Med; 1977; 23(4):206-13. PubMed ID: 201974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of pentoxifylline, xanthinol nicotinate and theophylline on the cardiovascular system, myocardial dynamics and left ventricular contractility of the dog in short-system, experiments].
    Komarek J; Cartheuser C
    Arzneimittelforschung; 1977; 27(10):1932-9. PubMed ID: 579103
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I; Molnár G
    Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of the beta1-24 corticotropic hormone, angiotensin II and xanthinol nicotinate on the kinetics of aldosterone (author's transl)].
    Pinsker P; Bultasová H; Bláha V; Vavrejn B
    Cas Lek Cesk; 1977 Jan; 116(2):35-8. PubMed ID: 191194
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological evaluation of xanthinol nicotinate (complamin).
    Galal E; Moustafa M; el-Gohary N; el-Mahdy SA; el-S Ali HI; Radwan AG
    J Egypt Med Assoc; 1976; 59(1-2):141-9. PubMed ID: 1032367
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
    Vámosi B; Molnár L; Demeter J; Túry F
    Arzneimittelforschung; 1976; 26(10a):1980-4. PubMed ID: 1037229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Features of lipolysis and several lipid and carbohydrate metabolism interrelationships under normal conditions, in atherosclerosis, and in diabetes mellitus].
    Lipovetskiĭ BM
    Ter Arkh; 1972 Apr; 44(4):8-14. PubMed ID: 4340646
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.
    Taskinen MR; Bogardus C; Kennedy A; Howard BV
    J Clin Invest; 1985 Aug; 76(2):637-44. PubMed ID: 3897287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD
    Med Monatsschr; 1976 Apr; 30(4):178-80. PubMed ID: 958145
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of nicotinic acid and xanthinol nicotinate on human memory in different categories of age. A double blind study.
    Loriaux SM; Deijen JB; Orlebeke JF; De Swart JH
    Psychopharmacology (Berl); 1985; 87(4):390-5. PubMed ID: 3936095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hyperlipidemia with xanthinol nicotinate as opposed to low fat diet].
    Baumann J; Martschick R
    Med Welt; 1982 Jan; 33(4):139-41. PubMed ID: 7062844
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of pentoxyfylline and xanthinol nicotinate on the overall blood pressure and tonus of cerebral and peripheral vessels].
    Gaevyĭ MD; Sankina TV; Nagornaia GV
    Farmakol Toksikol; 1984; 47(1):53-7. PubMed ID: 6705904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of weight reduction on carbohydrate and fatty-acid metabolism in obese, maturity-onset diabetic patients].
    Haller H; Zschornack M; Julius U; Hanefeld M; Haller H
    Z Gesamte Inn Med; 1975 May; 30(10):54-6. PubMed ID: 1199245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.